Low levels of phosphate can disrupt bone ossification and predispose to fractures. FGF23 is one of the major determinants of phosphate homeostasis, acting to increase urinary phosphate excretion. However, the regulation of FGF23 is incompletely understood. In this issue of the JCI, Smith et al. show that the cleaved form of αKlotho, the membrane-bound form of which is an FGF23 coreceptor, serves as a novel endocrine regulator of phosphate homeostasis, capable of inducing FGF23 production in osteocytes.
Harald Jüppner, Myles Wolf
Title and authors | Publication | Year |
---|---|---|
FGF23 and klotho at the intersection of kidney and cardiovascular disease.
Edmonston D, Grabner A, Wolf M |
Nature reviews. Cardiology | 2023 |
NFκB-sensitive Orai1 expression in the regulation of FGF23 release
B Zhang, J Yan, AT Umbach, H Fakhri, A Fajol, S Schmidt, MS Salker, H Chen, D Alexander, D Spichtig, A Daryadel, CA Wagner, M Föller, F Lang |
Journal of Molecular Medicine | 2015 |
Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study
R Giuseppe, T Kühn, F Hirche, B Buijsse, J Dierkes, A Fritsche, R Kaaks, H Boeing, GI Stangl, C Weikert, LR James |
PloS one | 2015 |
Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
M Leifheit-Nestler, R Siemer, K Flasbart, B Richter, F Kirchhoff, WH Ziegler, M Klintschar, JU Becker, A Erbersdobler, C Aufricht, T Seeman, DC Fischer, C Faul, D Haffner |
Nephrology Dialysis Transplantation | 2015 |
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
J Silver, T Naveh-Many |
Nature Reviews Nephrology | 2013 |